Navigation Links
No Majority in Favor of Banning Key Crop Protection Technology
Date:3/15/2013

BASEL, Switzerland, March 15, 2013 /PRNewswire/ --

Syngenta today responded to the failure of the European Commission to win support for an EU-wide ban on neonicotinoid pesticides. A majority of Member States refused to support the proposal to restrict their use on all bee attractive crops. The Commission must now decide whether to appeal the decision or amend its proposal.

Syngenta Chief Operating Officer, John Atkin , said: "We are pleased that EU Member States did not support the European Commission's shamefully political proposal. Restricting the use of this vital crop protection technology will do nothing to help improve bee health."

Syngenta has repeatedly highlighted that the European Commission tried to justify its actions on the basis of a hurried and highly theoretical review by the European Food Safety Agency (EFSA). This review made fundamental mistakes which led to a serious over-estimation of the amount of pesticide bees are exposed to under field conditions. It also ignored key studies and independent monitoring by governments which prove the safety of neonicotinoid pesticides.

The decline in bee health is one of the biggest challenges facing agriculture. However, even the European Commission's own data show that pesticides play a negligible role compared to diseases, viruses and loss of habitat.

Syngenta urged the European Commission to broaden efforts to tackle the real causes of the decline in bee health rather than continuing to focus on neonicotinoid pesticides, which deliver significant socio-economic and environmental benefits.

Syngenta has, for many years, supported bee health through Operation Pollinator http://www.operationpollinator.com. Syngenta's business is based upon biodiversity, including thriving pollinators, and the company remains committed to enhancing ecosystems wherever it operates in the world.

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to http://www.syngenta.com

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions.Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements.We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties.Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

http://www.syngenta.com


'/>"/>
SOURCE Syngenta Crop Protection AG
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
2. Genesis Biopharma Mentioned Favorably in BioMedReports Article
3. OrbusNeichs Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up
4. First-to-Market Online Identity Theft Protection - Allweb Technologies Launches AllWebID
5. Secretary of Department of Environmental Protection, Michael Krancer, to Facilitate Networking Session at Pittcon 2013
6. Human Research Protection and Understanding the Landscape of AAHRPP Accreditation
7. A possible answer for protection against chemical/biological agents, fuel leaks, and coffee stains
8. Live Webinar on Protection of Phase 1 Research Volunteers
9. Biotechnology and Environmental Protection at this Years ACHEMA
10. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
(Date:2/23/2017)... ... ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC 501(c)3 non-profit, ... is to advance global health and highlight the greater good of clinical trial participation ... trial volunteer. The vision of GGI is to serve as a philanthropic connector between ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):